Symetrify

Symetrify is the developer of the L-PACT, a neuromechanical wearable training device for assessing, treating, and preventing spinal kinetic dysfunctions related to chronic low back pain (CLBP). The L-PACT targets the functional-mechanical root cause of CLBP by balancing the functional motion of the lumbo-pelvic load distribution axis base, providing an automatic training solution to stop the degenerative process that leads to CLBP over time. The L-PACT trains the body’s self-neurological regulation to balance postural kinetic function through a safe, short, noninvasive automated process designed to reduce uneven pressure loads on intervertebral discs, joints, and supporting structures. Based on data-driven AI algorithms, the technology provides predictive markers for developing low back motion imbalances, offering personalized, long-lasting therapeutic effects for patients and increased treatment capacity and efficiency for clinicians and clinics.

Symetrify has raised $1M in total funding across 1 rounds. The company is currently at the Seed stage. Key investors include eHealth Ventures, Israel Innovation Authority.

Symetrify was founded in 2022 by Asher Castiel (Co-founder), Ami Eyal (CMO, R&D).

Symetrify operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics, Digital Healthcare, Digital Therapeutics, with core technologies in Semiconductors & Electronics, Wearables, Artificial Intelligence, Platforms & Interfaces, Software. Target customers: Healthcare & Life Sciences, Healthcare, Providers.

Symetrify is based in Modiin, Modi'in-Maccabim-Re'ut, Israel, Center District.